Memphasys Limited (ASX:MEM)
0.0060
-0.0010 (-14.29%)
Feb 11, 2026, 1:36 PM AEST
Memphasys Revenue
In the fiscal year ending June 30, 2025, Memphasys had annual revenue of 526.92K AUD with 237.77% growth. Memphasys had revenue of 201.58K in the half year ending June 30, 2025, a decrease of -49.10%.
Revenue
526.92K
Revenue Growth
+237.77%
P/S Ratio
35.70
Revenue / Employee
21.96K
Employees
24
Market Cap
18.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 526.92K | 370.92K | 237.77% |
| Jun 30, 2024 | 156.00K | -468.37K | -75.01% |
| Jun 30, 2023 | 624.37K | 53.29K | 9.33% |
| Jun 30, 2022 | 571.08K | 359.60K | 170.04% |
| Jun 30, 2021 | 211.48K | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Micro-X | 13.05M |
| ImpediMed | 12.72M |
| CurveBeam AI | 12.10M |
| Control Bionics | 6.14M |
| CONNEQT Health | 6.05M |
| Atomo Diagnostics | 3.79M |